A pharmaco-economic analysis of patients with schizophrenia switching to generic risperidone involving a possible compliance loss

• Auteurs principaux: Möller Hans-Jürgen (Auteur), Heeg Bart (Auteur), Treur Maarten (Auteur), Schmeding Annette (Auteur), van Hout Ben (Auteur)
• Format: Livre
• Publié: BMC, 2009-02-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>As schizophrenia patients are typically suspicious of, or are hostile to changes they may be reluctant to accept generic substitution, possibly affecting compliance. This may counteract drug costs savings due to less symptom control...